Preston Klassen
2014 - Orexigen Therapeutics
In 2014, Preston Klassen earned a total compensation of $1.6M as Executive Vice President, Global Product Development at Orexigen Therapeutics, a 2% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $178,248 |
|---|---|
| Option Awards | $1,040,191 |
| Salary | $379,250 |
| Other | $180 |
| Total | $1,597,869 |
Klassen received $1M in option awards, accounting for 65% of the total pay in 2014.
Klassen also received $178.2K in non-equity incentive plan, $379.3K in salary and $180 in other compensation.
Rankings
In 2014, Preston Klassen's compensation ranked 5,479th out of 13,032 executives tracked by ExecPay. In other words, Klassen earned more than 58.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,479 out of 13,032 | 58th |
Division Manufacturing | 1,962 out of 4,966 | 61st |
Major group Chemicals And Allied Products | 663 out of 1,686 | 61st |
Industry group Drugs | 513 out of 1,365 | 62nd |
Industry Pharmaceutical Preparations | 402 out of 1,043 | 62nd |
Source: SEC filing on May 27, 2016.
Klassen's colleagues
We found four more compensation records of executives who worked with Preston Klassen at Orexigen Therapeutics in 2014.